TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Atlas Antibodies AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
107,247
|
104,643
|
106,216 |
Financial expenses |
16,439
|
6,836
|
3,364 |
Earnings before taxes |
34,023
|
54,979
|
41,957 |
EBITDA |
39,441
|
34,716
|
93,186 |
Total assets |
1,978,470
|
1,942,817
|
2,063,163 |
Current assets |
203,051
|
170,322
|
124,932 |
Current liabilities |
10,338
|
13,949
|
13,879 |
Equity capital |
1,623,836
|
1,588,827
|
1,683,198 |
- share capital |
328
|
327
|
356 |
Employees (average) |
70
|
82
|
79 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
82.1%
|
81.8%
|
81.6% |
Turnover per employee |
1,532
|
1,276
|
1,345 |
Profit as a percentage of turnover |
31.7%
|
52.5%
|
39.5% |
Return on assets (ROA) |
2.6%
|
3.2%
|
2.2% |
Current ratio |
1964.1%
|
1221.0%
|
900.2% |
Return on equity (ROE) |
2.1%
|
3.5%
|
2.5% |
Change turnover |
2,065
|
7,030
|
13,453 |
Change turnover % |
2%
|
7%
|
15% |
Chg. No. of employees |
-12
|
3
|
13 |
Chg. No. of employees % |
-15%
|
4%
|
20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.